In the experimental models of focal cerebral ischemia, Li et al. (2017) generated a GFAP promoter-controlled IL-15–expressing transgenic mouse line, and found enlarged brain infarcts and exacerbated neurological deficits (Li et al., 2017). This evidence concerns the gene GFAP and brain infarction.